Matthew W. Foehr, President and COO at LIGAND PHARMACEUTICALS INC (LGND), sold 17,680 shares at $109.67 ($1.9M) on 2021-08-04, disclosed to the SEC on 2021-08-05.
Open-market sale of $1.9M LGND by President and COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $109.67 | 8,840 | $969K | 50.0% |
| 2 | $109.67 | 8,840 | $969K | 50.0% |
| Total | $109.67 avg | 17,680 | $1.9M | 100% |
| Filing → |
| OABI | SELL | 2026-02-17 | $35K | — | Filing → |
| VKTX | SELL | 2026-01-05 | $1.1M | — | Filing → |
| OABI | SELL | 2025-12-09 | $27K | — | Filing → |